A coin-sized device with no battery, no wires, and no deep surgical penetration into the brain just cleared its biggest regulatory hurdle. In late April 2026, the FDA granted Motif Neurotech an ...

A wireless brain implant for treatment-resistant depression has received FDA clearance for human trials in the United States.

MintNeuro, a pioneer of scalable, low-power semiconductor technology for neural implant applications, and Motif Neurotech, a therapeutic brain-computer interface (BCI) company developing miniature ...

The FDA has authorized the first human trial of a brain-computer interface designed to treat severe, treatment-resistant depression. Created by Motif Neurotech, the small implant works with a wireless ...

While many brain-computer interface companies are focused on helping paralyzed people communicate, Motif Neurotech is ...

CorTec GmbH today announced that the first participant in the University of Washington’s NIH-funded clinical trial of the Brain Interchange™ BCI system has successfully controlled a computer through ...

By integrating sub-50ms end-to-end latency with BCI-driven functional electrical stimulation (BCI-FES), the system enables a ...

CorTec today announced a major milestone for the first participant in a trial for its Brain Interchange brain-computer ...

A research team has published details of a brain-computer interface that abandons the conventional approach of ...

Aurora surgeons implanted a BCI in higher brain regions. The patient reported feeling fingers move after surgery.

ANN ARBOR, MI -- One of the first brain-computer interface clinics in the country has opened in Ann Arbor. University of Michigan Health opened its clinic to patients with severe motor and speech ...